tiprankstipranks
Repare Therapeutics Inc (RPTX)
NASDAQ:RPTX
US Market

Repare Therapeutics (RPTX) Stock Investors

282 Followers
Based on 733,923 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RPTX
On average, investors allocate 2.49% of their portfolios to RPTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 733,923 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RPTX

2.8%
Last 7
Days
28.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RPTX, out of 733,923 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RPTX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.61%
$6.49
Increased
0.58%
$5.56
Based on the activity of 13,820 investors who made their portfolios public
The table shows changes in RPTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RPTX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Trade Desk
4.70%
-0.21%
-0.64%
42.14B
Technology
Riot Platforms
4.97%
-0.38%
+2.45%
2.82B
Financial
ChargePoint Holdings
3.99%
-0.74%
-4.14%
783.22M
Consumer Cyclical
Coherus Biosciences
2.60%
-0.95%
-5.75%
238.63M
Healthcare
Block
4.34%
-0.56%
-2.14%
43.93B
Technology
Marathon Digital Holdings
5.51%
+0.26%
-2.01%
4.93B
Financial
UiPath
3.51%
+0.18%
-0.98%
11.57B
Technology
Mercadolibre
5.54%
-0.20%
+0.85%
85.37B
Consumer Cyclical
Enphase Energy
5.03%
-1.26%
-3.81%
15.93B
Technology
Shopify
5.23%
+1.67%
+0.84%
74.69B
Technology
Based on the activity of 733,923 active portfolios
Open your Smart Portfolio

RPTX Investor Analysis

RPTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.8%
of RPTX holders
are under 35
Average Segment Performance
Average P/E Ratio20.00
Beta6.11
Dividend Yield5.28%
RPTX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
47.1%
of RPTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.45
Beta10.75
Dividend Yield18.14%
RPTX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
43.1%
of RPTX holders
are over 55
Average Segment Performance
Average P/E Ratio18.60
Beta3.83
Dividend Yield6.02%
Overview of age group and performance of RPTX stock investors
See who invests in RPTX according to age group and performance.

FAQ

How many retail Investors hold RPTX?
<0.1% of TipRanks' retail investors hold RPTX in their portfolios.
    What is RPTX Investor Sentiment?
    RPTX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of RPTX in the last 7 days?
      ▲ 2.8% of TipRanks' retail investors changed their holding of RPTX in the last 7 days.
        What percentage of retail investors changed their holding of RPTX in the last 30 days?
        ▲ 28.8% of TipRanks' retail investors changed their holding of RPTX in the last 30 days.
          What is the average age of retail investors who hold RPTX?
          The average age of RPTX Holders is between 35–55.
            What other stocks have RPTX investors also bought?
            RPTX Investors also bought TTD, RIOT, CHPT, CHRS, SQ, MARA, PATH, MELI, ENPH, SHOP.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALKSAlkermes
              ALNYAlnylam Pharma
              BDXBecton Dickinson
              BCRXBioCryst
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis